Drug intelligence / Profile preview

periplaneta americana aqueous extract fraction 3-10 kDa

Development stage
Preclinical
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Periplaneta americana aqueous extract fraction 3-10 kDa (PAW2) is a biologic fraction derived from the American cockroach (*Periplaneta americana* L.) that is being investigated as a potential therapeutic agent for ulcerative colitis. This specific fraction is obtained through sequential ultrafiltration of aqueous extracts from *Periplaneta americana*, specifically retaining molecules with a molecular weight between 3 and 10 kDa, which include bioactive peptides, proteins, and polysaccharides. In preclinical studies using DSS-induced murine models of ulcerative colitis, PAW2 demonstrated significant anti-inflammatory effects by inhibiting the TLR4/MyD88/NF-κB signaling pathway and reducing the production of pro-inflammatory cytokines such as TNF-α, IL-17A, and IFN-γ. Additionally, PAW2 helps preserve intestinal barrier integrity by upregulating tight junction proteins, including occludin-1 and ZO-1, and modulates the composition of the gut microbiota to alleviate dysbiosis.

Other names
Periplaneta americana aqueous extract fraction 3-10 kDaPAW2PAW-2PAW 2
02

Targets

RELA (Nuclear Factor Kappa B Subunit p65)MYD88 (Myeloid differentiation primary response protein MyD88)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on periplaneta americana aqueous extract fraction 3-10 kDa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on periplaneta americana aqueous extract fraction 3-10 kDa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call